May N. Taw

May N. Taw

Auto-generated profile, based on publicly available information

May N. Taw

Department of Microbiology, Cornell University, Ithaca, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
BSBelen Sotomayor
Belen Sotomayor
TDThomas C. Donahue
Thomas C. Donahue
SMSai Pooja Mahajan
Sai Pooja Mahajan
MTMay N. Taw
May N. Taw
SHSophia W. Hulbert
Sophia W. Hulbert
Matthew Peter DeLisaMatthew Peter DeLisa
Matthew Peter DeLisa
Human immunoglobulin G (IgG) antibodies are a major class of biotherapeutics and undergo N-linked glycosylation in their Fc domain, which is critical for immune functions and therapeutic activity. Hence, technologies for producing authentically glycosylated IgGs are in high demand. Previous attempts to engineer Escherichia coli for this purpose have met limited success due in part to the lack of oligosaccharyltransferase (OST) enzymes that can install N-glycans at the conserved N297 site in the Fc region. Here, we identify a single-subunit OST from Desulfovibrio marinus with relaxed substrate specificity that catalyzes glycosylation of native Fc acceptor sites. By chemoenzymatic remodeling the attached bacterial glycans to homogeneous, asialo complex-type G2 N-glycans, the E. coli-derived Fc binds human FcγRIIIa/CD16a, a key receptor for antibody-dependent cellular cytotoxicity (ADCC). Overall, the discovery of D. marinus OST provides previously unavailable biocatalytic capabilities and sets the stage for using E. coli to produce fully human antibodies.

12 May 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
MTMay N. Taw
May N. Taw
JBJason T. Boock
Jason T. Boock
DKDaniel Kim
Daniel Kim
MRMark A. Rocco
Mark A. Rocco
DWDujduan Waraho-Zhmayev
Dujduan Waraho-Zhmayev
Matthew Peter DeLisaMatthew Peter DeLisa
Matthew Peter DeLisa
The twin-arginine translocation (Tat) pathway involves an inbuilt quality control (QC) system that synchronizes proofreading of substrate protein folding with lipid bilayer transport. However, the molecular details of this QC mechanism remain poorly understood. Here, we hypothesized that the conformational state of Tat substrates is directly sensed by the TatB component of the bacterial Tat translocase. In support of this hypothesis, several TatB variants in which the cytoplasmic membrane-extrinsic domain was either truncated or mutated in the vicinity of a conserved, highly flexible α-helical domain were observed to form functional translocases in vivo that had compromised QC activity as evidenced by the uncharacteristic export of several misfolded protein substrates. In vitro folding experiments revealed that the membrane-extrinsic domain of TatB possessed general chaperone activity, transiently binding to highly structured, partially unfolded intermediates of a model protein, citrate synthase, thereby preventing its irreversible aggregation and stabilizing the active species. Collectively, these results suggest that the Tat translocase may use chaperone-like client recognition to monitor the conformational status of its substrates.

12 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
BSBelen Sotomayor
Belen Sotomayor
TDThomas C. Donahue
Thomas C. Donahue
SMSai Pooja Mahajan
Sai Pooja Mahajan
MTMay N. Taw
May N. Taw
SHSophia W. Hulbert
Sophia W. Hulbert
Matthew Peter DeLisaMatthew Peter DeLisa
Matthew Peter DeLisa
Human immunoglobulin G (IgG) antibodies are one of the most important classes of biotherapeutic agents and undergo glycosylation at the conserved N297 site in the C H 2 domain, which is critical for IgG Fc effector functions and anti-inflammatory activity. Hence, technologies for producing authentically glycosylated IgGs are in high demand. While attempts to engineer Escherichia coli for this purpose have been described, they have met limited success due in part to the lack of available oligosaccharyltransferase (OST) enzymes that can install N- linked glycans within the QYNST sequon of the IgG C H 2 domain. Here, we identified a previously uncharacterized single-subunit OST (ssOST) from the bacterium Desulfovibrio marinus that exhibited greatly relaxed substrate specificity and, as a result, was able to catalyze glycosylation of native C H 2 domains in the context of both a hinge-Fc fragment and a full-length IgG. Although the attached glycans were bacterial in origin, conversion to a homogeneous, asialo complex-type G2 N -glycan at the QYNST sequon of the E. coli -derived hinge-Fc was achieved via chemoenzymatic glycan remodeling. Importantly, the resulting G2-hinge-Fc exhibited strong binding to human FcγRIIIa (CD16a), one of the most potent receptors for eliciting antibody-dependent cellular cytotoxicity (ADCC). Taken together, the discovery of a unique ssOST from D. marinus provides previously unavailable biocatalytic capabilities to the bacterial glycoprotein engineering toolbox and opens the door to using E. coli for the production and glycoengineering of human IgGs and fragments derived thereof.